Statement on Passage of Diagnostic and Supplemental Imaging Legislation in Alaska

Susan G. Komen^®, the world’s leading breast cancer organization, today issued the following statement on the passage of critical breast imaging legislation in Alaska, SB 134. Diagnostic and supplemental imaging is a critical form of breast cancer screening for some high-risk individuals and an important step in determining the need for a biopsy to rule out or confirm breast cancer. SB 134 was approved by the Alaska legislature earlier this year and has now been enacted into law:

“We thank the Alaska legislature for their work to eliminate barriers to care so that people with state-regulated health plans receive their medically necessary diagnostic and supplemental imaging without any patient cost sharing,” said Molly Guthrie, Vice President of Policy and Advocacy at Susan G. Komen.

“Many Alaskans require diagnostic and supplemental breast imaging every year, yet some forgo them due to out-of-pocket costs. Not anymore. This life-saving legislation means they can now receive the breast imaging they require, leading to an earlier breast cancer diagnosis and often better health outcomes.”

“Komen will continue to advocate for legislation that ensures fair and equitable access to high-quality breast care for all, no matter their age, race, ethnicity, sexual orientation, gender identity, cancer stage or socio-economic status.”

Learn more about the legislation here.